BAM
ADMA icon

Bosun Asset Management’s ADMA Biologics ADMA Stock Holding History

Bosun Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,334
Closed -$334K – 73
2025
Q2 		$334K Sell
18,334
-13,326
-42% -$272K 0.1% 163
2025
Q1 		$628K Sell
31,660
-32,810
-51% -$567K 0.27% 95
2024
Q4 		$1.11M Sell
64,470
-11,766
-15% -$221K 0.48% 65
2024
Q3 		$1.52M Buy
76,236
+350
+0.5% +$5.44K 0.73% 30
2024
Q2 		$848K Buy
75,886
+17,318
+30% +$145K 0.5% 52
2024
Q1 		$387K Buy
+58,568
New +$320K 0.22% 128

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bosun Asset Management's ADMA Position: Q3 2025 in Review

Bosun Asset Management sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 18,334 shares — an estimated $334K sold.

Bosun Asset Management first reported a position in ADMA in Q1 2024 and held it in 6 quarters. The position peaked at $1.52M in Q3 2024. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Bosun Asset Management reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Bosun Asset Management sold 18,334 ADMA Biologics shares in Q3 2025, an estimated $334K.
  • Bosun Asset Management first reported a position in ADMA Biologics in Q1 2024 and held it in 6 quarters.
  • Bosun Asset Management's ADMA Biologics position peaked at $1.52M in Q3 2024.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Bosun Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.